Radiopharmacy giant Syncor International has cut a new three-year agreement and two-year renewal option with Broadlane, a major provider of supply chain services to the healthcare industry. The agreement, which takes effect immediately, establishes Syncor as the distributor of radiopharmaceuticals, including FDG, to Broadlane’s 572 acute care hospitals and 2335 subacute healthcare facilities. In addition to the sole source agreement, Broadlane will also make available to its members Syncor’s PharmaSeed I-125 brachytherapy seeds.

Radiopharmacy giant Syncor International has cut a new three-year agreement and two-year renewal option with Broadlane, a major provider of supply chain services to the healthcare industry. The agreement, which takes effect immediately, establishes

Syncor signs with Broadlane